The landscape of genetics and biomarkers in bladder cancer.
作者信息
Rink Michael
机构信息
Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
出版信息
Transl Androl Urol. 2017 Dec;6(6):1027-1030. doi: 10.21037/tau.2017.11.12.
Abstract
摘要
相似文献
1
The landscape of genetics and biomarkers in bladder cancer.膀胱癌的遗传学与生物标志物概况
Transl Androl Urol. 2017 Dec;6(6):1027-1030. doi: 10.21037/tau.2017.11.12.
2
Genomic and Therapeutic Landscape of Non-muscle-invasive Bladder Cancer.非肌肉浸润性膀胱癌的基因组和治疗全景。
Urol Clin North Am. 2020 Feb;47(1):35-46. doi: 10.1016/j.ucl.2019.09.006.
3
The landscape of chimeric RNAs in bladder urothelial carcinoma.膀胱癌中嵌合 RNA 的研究现状。
Int J Biochem Cell Biol. 2019 May;110:50-58. doi: 10.1016/j.biocel.2019.02.007. Epub 2019 Feb 25.
4
Putting the "landscape" in landscape genetics.将“景观”融入景观遗传学。
Heredity (Edinb). 2007 Mar;98(3):128-42. doi: 10.1038/sj.hdy.6800917. Epub 2006 Nov 1.
5
Molecular genetics and genomics progress in urothelial bladder cancer.尿路上皮膀胱癌的分子遗传学和基因组学进展。
Semin Diagn Pathol. 2013 Nov;30(4):313-20. doi: 10.1053/j.semdp.2013.11.005. Epub 2013 Nov 11.
6
Perioperative systemic therapy for bladder cancer.膀胱癌的围手术期全身治疗。
Curr Opin Urol. 2019 May;29(3):220-226. doi: 10.1097/MOU.0000000000000600.
7
Landscape genetics of plants.植物的景观遗传学。
Trends Plant Sci. 2010 Dec;15(12):675-83. doi: 10.1016/j.tplants.2010.09.002.
8
Novel biomarkers in bladder cancer.膀胱癌中的新型生物标志物。
Urol Oncol. 2018 Mar;36(3):115-119. doi: 10.1016/j.urolonc.2018.01.009. Epub 2018 Feb 19.
9
SIU-ICUD consultation on bladder cancer: basic science.膀胱癌 SIU-ICUD 咨询：基础科学。
World J Urol. 2019 Jan;37(1):15-29. doi: 10.1007/s00345-018-2594-y. Epub 2018 Dec 13.
10
Navigating the pitfalls and promise of landscape genetics.应对景观遗传学的陷阱与前景
Mol Ecol. 2016 Feb;25(4):849-63. doi: 10.1111/mec.13527.
引用本文的文献
1
The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma.分子生物标志物在尿路上皮癌中的治疗及预后意义
Transl Cancer Res. 2020 Oct;9(10):6609-6623. doi: 10.21037/tcr-20-1243.
2
Immunotherapy in Bladder Cancer: Current Methods and Future Perspectives.膀胱癌的免疫疗法：当前方法与未来展望
Cancers (Basel). 2020 May 7;12(5):1181. doi: 10.3390/cancers12051181.
3
The current role of circulating biomarkers in non-muscle invasive bladder cancer.循环生物标志物在非肌层浸润性膀胱癌中的当前作用。
Transl Androl Urol. 2019 Feb;8(1):61-75. doi: 10.21037/tau.2018.11.05.
4
The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder.循环肿瘤细胞和循环肿瘤 DNA 在膀胱癌中的当前作用和未来方向。
World J Urol. 2019 Sep;37(9):1785-1799. doi: 10.1007/s00345-018-2543-9. Epub 2018 Oct 26.
本文引用的文献
1
Occupation and Bladder Cancer Phenotype: Identification of Workplace Patterns That Increase the Risk of Advanced Disease Beyond Overall Incidence.职业与膀胱癌表型：识别增加晚期疾病风险的工作场所模式，超出总体发病率。
Eur Urol Focus. 2018 Sep;4(5):725-730. doi: 10.1016/j.euf.2016.06.014. Epub 2016 Jul 20.
2
Smoking and Bladder Cancer: A Systematic Review of Risk and Outcomes.吸烟与膀胱癌：风险及预后的系统评价
Eur Urol Focus. 2015 Aug;1(1):17-27. doi: 10.1016/j.euf.2014.11.001. Epub 2015 May 19.
3
Systematic Review of Immune Checkpoint Inhibition in Urological Cancers.免疫检查点抑制剂在泌尿系统肿瘤中的系统评价
Eur Urol. 2017 Sep;72(3):411-423. doi: 10.1016/j.eururo.2017.06.012. Epub 2017 Jun 20.
4
Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.转移性尿路上皮癌转移灶切除术后的生存情况：一项系统评价和荟萃分析。
Bladder Cancer. 2017 Apr 27;3(2):121-132. doi: 10.3233/BLC-170108.
5
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.肌层浸润性膀胱癌分子亚型对新辅助化疗后反应和生存预测的影响。
Eur Urol. 2017 Oct;72(4):544-554. doi: 10.1016/j.eururo.2017.03.030. Epub 2017 Apr 5.
6
Liquid biopsies in bladder cancer-did we find the Holy Grail for biomarker analyses?膀胱癌的液体活检——我们找到生物标志物分析的圣杯了吗？
Transl Androl Urol. 2016 Dec;5(6):980-983. doi: 10.21037/tau.2016.09.03.
7
Emerging role of immunotherapy in urothelial carcinoma-Advanced disease.免疫疗法在尿路上皮癌晚期疾病中的新作用。
Urol Oncol. 2016 Dec;34(12):538-547. doi: 10.1016/j.urolonc.2016.10.017.
8
Bladder cancer.膀胱癌。
Lancet. 2016 Dec 3;388(10061):2796-2810. doi: 10.1016/S0140-6736(16)30512-8. Epub 2016 Jun 23.
9
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.EAU 指南：非肌层浸润性膀胱尿路上皮癌：2016 年更新版。
Eur Urol. 2017 Mar;71(3):447-461. doi: 10.1016/j.eururo.2016.05.041. Epub 2016 Jun 17.
10
Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors.超越黑色素瘤：抑制实体瘤中的PD-1/PD-L1通路。
Immunotherapy. 2016 May;8(5):583-600. doi: 10.2217/imt-2015-0029.
Zotero 插件